Despite this, HSPB5 overexpression was unable to modify the onset and progression of the disease in two different tg ALS (SOD1-G93A and SOD1-L126Z) mice [152], suggesting that this chaperone is not implicated in ALS and may not represent a therapeutic target against the disease. Here, SOD1 is linked to amyotrophic lateral sclerosis.